The Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and the National Library of Medicine (NLM) of the National Institutes of Health are announcing the following public workshop entitled “FDA/CDC/NLM Workshop on Promoting Semantic Interoperability of Laboratory Data.”
The purpose of the workshop is to receive and discuss input from stakeholders regarding proposed approaches to promoting the semantic interoperability of laboratory data between in vitro diagnostic devices and database systems, including laboratory information systems and electronic health records.
- Date, Time and Location
- Federal Register Notice
- Agenda
- Registration
- Contact Us
Date, Time and Location
This meeting will be held September 28, 2015, beginning at 8:00 am – 5:00 pm at the following location:
FDA White Oak Campus
10903 New Hampshire Avenue
Bldg. 31, Room 1503 (the Great Room)
Silver Spring, MD, 20993
- FDA Campus Information (Airports, Directions, Lodging Accommodations, Public Transportation, etc.)
The meeting will be webcast.
Draft Agenda
Registration to Attend the Workshop
If you wish to attend this Workshop, you must register by close of business on September 18, 2015.
If you wish to request to present during open public comment session, you must register by close of business on September 2, 2015.
- Name
- Title
- Affiliation, Company or Organization
- Email address
- Telephone number
- Request to Present During Open Public Comment Session and Topic You Wish To Address (deadline September 2, 2015)
- Relevant experience and/or expertise
There is no fee to register for the Workshop and registration will be on a firstcome, firstserved basis. Early registration is recommended because seating is limited.
If you wish to make an oral presentation during the open public comment session at the meeting you must indicate this at the time of registration. FDA requests that presentations focus on the areas defined in the Federal Register Notice. You should also identify which discussion topic you wish to address in your presentation and you must submit a brief statement that describes your experience and/or expertise relevant to your proposed presentation. FDA will do its best to accommodate requests to speak.
If you require special accommodations due to a disability, or need additional information regarding registration, please contact Susan Monahan, Office of Communication and Education, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Avenue, Bldg. 32, Silver Spring, MD 20993, 3017965661, [email protected].
Contact Us
For questions regarding workshop content please contact:
Steven Gitterman, Food and Drug Administration, WO 66 Rm 5518, 10903 New Hampshire Avenue, Silver Spring, MD 209930002, Tel: 3017966694, FAX: 3018472512, email: [email protected].
